08/04/2026
As the Medicare Advantage program grows, so does the federal government’s scrutiny of MAOs and downstream providers alike. Given recent regulatory and market developments, as well as the increasing availability and use of AI across the MA program, effective and proactive compliance safeguards for stakeholders can significantly limit long-term financial and operational risks. This ABA Health eSource article, by Devin Cohen, Matthew J. Westbrook, and Catherine Pellerin from Proskauer Rose LLP, explores how these ongoing and emerging trends and increased regulatory scrutiny across the MA program—the good, the bad, and the uncertain–can and likely will affect how stakeholders build effective safeguards.
Read More:
Combating healthcare FWA remains a top bipartisan enforcement priority. As the MA program grows, so does the federal government’s scrutiny of MAOs and downstream providers alike.